⌕
Enovis · ENOV · NYSE
Tenet 43 · Weak
Compare
$27.92+0.87%At closeTenet 43 · Weak
$27.92+0.24 (+0.87%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Enovis (ENOV) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● GlobeNewsWireNov 12, 2026 · 16:15 ETCOMPANY'S OWN WORDS
Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London

Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will be presenting at the…

● MarketBeatNov 7, 2026 · 02:23 ETEARNINGS EXPECTED BY FEB 22
What Enovis (ENOV) Said on Its Q3 Earnings Call

Enovis NYSE: ENOV reported third-quarter sales of $559 million and raised its full-year adjusted earnings outlook, as growth in its reconstructive business and improved cash generation helped offset what executives descr…

● Seeking AlphaNov 6, 2026 · 07:04 ETEARNINGS EXPECTED BY FEB 22
Enovis Corporation (ENOV) Q3 2026 Earnings Call Transcript

Enovis Corporation ( ENOV ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants Kyle Rose - Vice President of Investor Relations Damien McDonald - CEO & Director Phillip Berry - Senior VP & CFO Confer…

● Zacks Investment ResearchNov 5, 2026 · 08:36 ETEARNINGS EXPECTED BY FEB 22
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates

Enovis (ENOV) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.75 per share a year ago.…

● GlobeNewsWireNov 5, 2026 · 06:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 22
ENOVIS Announces Third Quarter 2026 Results

Dallas, TX, Nov. 05, 2026 (GLOBE NEWSWIRE) -- - Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third qu…

● GlobeNewsWireOct 8, 2026 · 08:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 22
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th

Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss…

● Defense WorldOct 6, 2026 · 10:14 ETEARNINGS EXPECTED BY FEB 22
electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head Comparison

electroCore (NASDAQ: ECOR - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the stren…

● Defense WorldOct 6, 2026 · 06:15 ET
Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)

Nexalin Technology (NASDAQ: NXL - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the…

● PRNewsWireSep 22, 2026 · 12:02 ETCOMPANY'S OWN WORDS
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program

Company expands its support from the American Joint Replacement Registry to include the Shoulder & Elbow Registry ROSEMONT, Ill., Sept. 22, 2026 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announc…

● Defense WorldSep 16, 2026 · 04:08 ET
Enovis (NYSE:ENOV) Hits New 52-Week Low – What’s Next?

Enovis Corporation (NYSE: ENOV - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday. The stock traded as low as $17.30 and last traded at $17.9220, with a volume of 2658431 share…

● Zacks Investment ResearchSep 3, 2026 · 13:00 ETEARNINGS EXPECTED BY FEB 22
What Makes Enovis (ENOV) a New Buy Stock

Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.…

● Zacks Investment ResearchSep 3, 2026 · 10:36 ETEARNINGS EXPECTED BY FEB 22
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates hig…

● Zacks Investment ResearchSep 2, 2026 · 14:36 ET
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition

ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.…

● Seeking AlphaSep 1, 2026 · 10:54 ET
Enovis Corporation (ENOV) M&A Call Transcript

Enovis Corporation (ENOV) M&A Call Transcript…

● MarketBeatSep 1, 2026 · 10:04 ET
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal

Enovis NYSE: ENOV said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its enabling-technology capabilities and …

● PRNewsWireSep 1, 2026 · 06:45 ET
eCential Robotics Announces Binding Offer from Enovis

eCential Robotics platform to join Enovis' enabling technology portfolio. GRENOBLE, France and FRANKLIN, Tenn.…

● GlobeNewsWireSep 1, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Dallas, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- – Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced today that it has entered into a binding offer to acquire eCential Robotics, a…

● GlobeNewsWireAug 31, 2026 · 16:15 ETCOMPANY'S OWN WORDS
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Dallas, TX, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells Fargo HealthCare confere…

● Seeking AlphaAug 21, 2026 · 10:22 ET
Enovis Corporation: Arvis Is Disrupting The Health Care Industry

Enovis Corporation is rated a buy, trading at a 7x EBITDA multiple versus a sector median of 14.7x, with significant upside if Arvis succeeds. Arvis, a zero-footprint, wearable augmented reality device for orthopedic sur…

● Seeking AlphaAug 20, 2026 · 10:39 ETEARNINGS EXPECTED BY FEB 22
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land

Enovis is gaining share in joint reconstruction, leveraging new products and capitalizing on competitor disruptions. Q2 results beat expectations, with 4% organic revenue growth and improved margins, but guidance now ant…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 22. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just ENOV · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.